US Stock MarketDetailed Quotes
TRIB Trinity Biotech
- 1.2200
- -0.0800-6.15%
Close Nov 22 16:00 ET
- 1.2400
- +0.0200+1.64%
Post 19:45 ET
33.33MMarket Cap-537P/E (TTM)
1.2900High1.1900Low148.70KVolume1.2900Open1.3000Pre Close182.90KTurnover0.66%Turnover RatioLossP/E (Static)27.32MShares3.550052wk High-1.27P/B27.63MFloat Cap1.050952wk Low--Dividend TTM22.65MShs Float143.4487Historical High--Div YieldTTM7.69%Amplitude1.0500Historical Low1.2290Avg Price1Lot Size
Trinity Biotech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.24%15.15M | 13.99%15.84M | -0.84%14.7M | -9.10%56.83M | -14.61%13.43M | -6.54%14.68M | -9.85%13.9M | -5.40%14.83M | -22.96%62.52M | 104.02%15.73M |
| Operating revenue | 3.24%15.15M | 13.99%15.84M | -0.84%14.7M | -9.10%56.83M | -14.61%13.43M | -6.54%14.68M | -9.85%13.9M | -5.40%14.83M | -22.96%62.52M | 104.02%15.73M |
| Cost of revenue | -5.32%9.84M | 13.99%10.11M | -0.80%9.18M | -17.39%37.38M | -14.39%8.86M | -32.38%10.4M | -9.83%8.87M | -4.51%9.26M | -5.12%45.25M | 103.20%10.35M |
| Gross profit | 24.02%5.31M | 14.00%5.73M | -0.92%5.52M | 12.64%19.45M | -15.03%4.57M | 1,200.91%4.28M | -9.87%5.03M | -6.84%5.57M | -48.38%17.27M | 105.62%5.38M |
| Operating expense | -14.27%7.53M | -18.37%7.4M | -9.79%8.56M | 14.96%35.39M | -23.34%8.06M | 42.26%8.78M | 31.18%9.07M | 31.87%9.49M | 14.03%30.79M | 26.71%10.51M |
| Selling and administrative expenses | -15.15%6.52M | -18.75%6.42M | -13.08%7.5M | 15.45%31.15M | -28.30%6.94M | 49.15%7.68M | 33.33%7.91M | 38.47%8.63M | 19.91%26.98M | 184.39%9.67M |
| Research and development costs | -13.60%1.01M | -19.63%991K | 26.63%1.09M | 5.82%4.38M | -4.20%1.12M | 14.27%1.17M | 25.30%1.23M | -10.88%860K | -7.98%4.14M | 23.91%1.17M |
| Other operating expenses | ---- | 81.69%-13K | ---29K | 58.56%-138K | 100.91%3K | -6,900.00%-70K | -7,000.00%-71K | ---- | ---333K | ---331K |
| Operating profit | 50.69%-2.22M | 58.71%-1.67M | 22.40%-3.04M | -17.92%-15.94M | 32.03%-3.49M | 22.98%-4.5M | -203.31%-4.04M | -222.29%-3.92M | -309.48%-13.52M | 9.62%-5.13M |
| Net non-operating interest income expense | -11.91%-2.24M | 49.19%-1.91M | 91.28%-209K | 20.58%-8.98M | -107.56%-821K | -7.71%-2M | 54.69%-3.76M | 80.03%-2.4M | -92.82%-11.3M | 464.54%10.86M |
| Non-operating interest income | 117.99%848K | ---- | -64.29%55K | --0 | -83.89%-605K | 18.24%389K | --62K | -29.36%154K | --0 | 72.81%-329K |
| Non-operating interest expense | 29.20%3.08M | 41.83%5.42M | -89.65%264K | -12.00%10.15M | 112.66%1.39M | 9.29%2.39M | -53.94%3.82M | -79.13%2.55M | 111.71%11.53M | -911.56%-10.96M |
| Total other finance cost | ---- | ---- | ---- | -411.35%-1.17M | ---- | ---- | ---- | ---- | -154.78%-229K | ---- |
| Other net income (expense) | -339K | 36.66%-12.01M | 92.62%-1.19M | -1,983.82%-10.82M | -653.46%-18.96M | -554.65%-16.15M | ||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.68M | ---- |
| Special income (charges) | ---339K | ---- | ---- | -29.39%-12.01M | 81.54%-1.2M | --0 | -1,983.82%-10.82M | ---- | -268.33%-9.28M | -282.47%-6.47M |
| -Less：Restructuring and merger&acquisition | --339K | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 79.30%9.61M | ---- | ---- | ---- | ---- | -15.78%5.36M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | -73.71%905K | ---- | ---- | ---- | ---- | 177.83%3.44M | ---- |
| -Write off | --0 | ---- | ---- | 211.20%1.5M | -300.47%-9.32M | --0 | 1,983.82%10.82M | ---- | -17.32%482K | 57.59%-2.33M |
| Other non- operating income (expenses) | ---- | ---- | ---- | 0.00%3K | ---- | ---- | ---- | ---- | -25.00%3K | ---- |
| Income before tax | 26.22%-4.79M | 62.99%-6.89M | 48.54%-3.25M | 15.65%-36.93M | 47.23%-5.5M | 34.93%-6.5M | -83.38%-18.61M | 52.22%-6.32M | -2,175.47%-43.78M | -104.25%-10.43M |
| Income tax | -115.77%-35K | 50.94%-131K | 709.09%67K | 69.59%-59K | 76.92%-3K | 11,000.00%222K | -734.38%-267K | 92.67%-11K | -162.16%-194K | 98.80%-13K |
| Net income | 29.19%-4.76M | -12.84%-6.76M | 42.90%-3.32M | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M |
| Net income continuous Operations | 29.18%-4.76M | 63.17%-6.76M | 47.39%-3.32M | 15.41%-36.87M | 47.20%-5.5M | 32.72%-6.72M | -81.32%-18.35M | 51.76%-6.31M | -2,256.00%-43.59M | -159.07%-10.41M |
| Net income discontinuous operations | --0 | --0 | --0 | 398.64%12.85M | -100.90%-3K | -100.10%-1K | 2,899.51%12.36M | -37.29%496K | -5.43%2.58M | -87.91%333K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 29.19%-4.76M | -12.84%-6.76M | 42.90%-3.32M | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 29.19%-4.76M | -12.84%-6.76M | 42.90%-3.32M | 41.43%-24.02M | 45.42%-5.5M | 24.86%-6.72M | 38.31%-5.99M | 52.69%-5.81M | -4,786.74%-41.01M | -696.76%-10.08M |
| Basic earnings per share | 47.73%-0.46 | 7.16%-0.726 | 50.85%-0.374 | 46.67%-3.2 | 45.66%-0.72 | 25.11%-0.88 | 44.93%-0.782 | 69.56%-0.761 | -3,100.00%-6 | -341.67%-1.325 |
| Diluted earnings per share | 47.73%-0.46 | 7.16%-0.726 | 50.85%-0.374 | 46.67%-3.2 | 45.66%-0.72 | 25.11%-0.88 | 44.93%-0.782 | 69.56%-0.761 | -3,100.00%-6 | -341.67%-1.325 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data